Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2022PLoS ONEOpen Access

Development and validation of a new prognostic index for mortality risk in multimorbid adults

View Full Paper
Ask AI
Bookmark
Share

Authors

VGViktoria GastensACArnaud ChioléroDADaniela Anker

Discussion

Loading...

Member takes

Overview

Cohort study reveals key predictors of one-year mortality in older multimorbid adults, highlighting a novel risk stratification tool.

Key Points

  • To develop and internally validate a point-based 1-year mortality prognostic index tailored specifically for older adults with multimorbidity and polypharmacy.
  • Analyzed data from 805 hospitalized adults aged ≥70 years with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 medications) from the OPERAM cohort in Bern, Switzerland.
  • Identified predictors of time to 1-year all-cause mortality using a parametric Weibull regression model with backward stepwise selection.
  • Internally validated the model and corrected for optimism using bootstrapping techniques, assessing performance via the C statistic and calibration slope.
  • Over 1 year of follow-up, 158 of 805 participants (20%) died.
  • Predictors included age, Charlson Comorbidity Index, medication count, BMI, prior hospitalizations, Barthel Index, and nursing home residency, yielding an optimism-corrected C statistic of 0.70 and calibration slope of 0.93.
  • The point-based score stratified participants into 1-year mortality rates of 7% in the low-risk group, 19% in the moderate-risk group, and 37% in the high-risk group.

Cite This Study

Gastens et al. (2022) studied this question.

synapsesocial.com/papers/6a747e94fc5fd65369f53db4https://doi.org/10.1371/journal.pone.0271923
View Full Paper
Ask AI
Bookmark
Share